Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | CA4 | P22748 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | GSR | P00390 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19988476 | 0.97 | — | — | |
| SCHEMBL4175207 | 0.97 | — | — | |
| SCHEMBL12829162 | 0.97 | — | — | |
| SCHEMBL13807049 | 0.97 | — | — | |
| SCHEMBL1274061 | 0.92 | — | — | |
| SCHEMBL1274067 | 0.92 | — | — | |
| SCHEMBL1274063 | 0.92 | — | — | |
| SCHEMBL1819105 | 0.80 | — | — | |
| SCHEMBL17798840 | 0.80 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL7130840 | 0.77 | GBA1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1162189-B1 | Process for producing 2-vinylcyclododecanone. | TAKASAGO PERFUMERY CO LTD (JP) | 2007-02-28 | — | — | EP | disclosed |
| US-6548711-B2 | Heating 2-ethylidenecyclododecanone in the presence of a catalyst to establish an isomeration equilibrium state between said Z-isomer, E-isomer and 2- vinylcyclodecanone and separating the 2-vinylcyclododecanone by fractionation | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2003-04-15 | — | — | US | disclosed |
| US-20020038056-A1 | Process for producing 2-vinylcyclododecanone | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2002-03-28 | — | — | US | disclosed |
| EP-1162189-A2 | Process for producing 2-vinylcyclododecanone. | Takasago International Corporation (JP) | 2001-12-12 | — | — | EP | disclosed |
| EP-0955285-B1 | Process and apparatus for production of 5-cyclohexadecen-1-one | TAKASAGO PERFUMERY CO LTD (JP) | 2001-11-14 | — | — | EP | disclosed |
| US-6169211-B1 | HEATING 1,2-DIVINYLCYCLODODECANOL IN THE VAPOR PHASE AT HIGH TEMPERATURE UNDER REDUCED PRESSURE TO FORM 5-CYCLOHEXADECEN-1-ONE | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2001-01-02 | — | — | US | disclosed |
| EP-0955285-A1 | Process and apparatus for production of 5-cyclohexadecen-1-one | Takasago International Corporation (JP) | 1999-11-10 | — | — | EP | disclosed |
| US-3923699-A | Cyclohexadecenone-5 perfume compositions | TAKASAGO PERFUMERY CO LTD | 1975-12-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020038056-A1 | Process for producing 2-vinylcyclododecanone | CYP4A22, CCNY, CYP2J2 | CA1 4157/4885CA2 3672/4885CA4 1785/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.